Board Meeting2 Jul 2026, 06:50 pm
Asston Pharma Approves ₹27.7 Cr Preferential Issue
AI Summary
Asston Pharmaceuticals Ltd announced that its Board of Directors has approved a preferential issue of up to 24,10,431 equity shares at ₹115 per share, aggregating to ₹27.72 crore. These shares will be issued to non-promoter category investors on a cash basis, subject to shareholder and regulatory approvals. The company also announced the convening of an Extraordinary General Meeting (EGM) on July 31, 2026, to seek shareholder consent for this issuance. The board meeting took place on July 02, 2026, from 3:00 PM to 5:00 PM.
Key Highlights
- Board approves preferential issue of 24.1 lakh equity shares.
- Issue price set at ₹115 per share, raising ₹27.72 crore.
- Shares to be issued to non-promoter category investors.
- EGM scheduled for July 31, 2026, to seek shareholder approval.
- Subject to necessary statutory and regulatory approvals.
Price Impact
More from APL